Cargando…

Siglec-7/-9 ligands shield tumor cells from NK cell attack

Detalles Bibliográficos
Autores principales:	Jandus, Camilla, Boligan, Kayluz Frias, Chijioke, Obinna, Liu, He, Dahlhaus, Meike, Démoulins, Thomas, Schneider, Christoph, Wehrli, Marc, Hunger, Robert E, Baerlocher, Gabriela M, Simon, Hans-Uwe, Romero, Pedro, Münz, Christian, von Gunten, Stephan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2013
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3991059/ http://dx.doi.org/10.1186/2051-1426-1-S1-P157

Ejemplares similares

The NK cell checkpoint NKG2A maintains expansion capacity of human NK cells
por: Kaulfuss, Meike, et al.
Publicado: (2023)

NK Cell Influence on the Outcome of Primary Epstein–Barr Virus Infection
por: Chijioke, Obinna, et al.
Publicado: (2016)

Siglec-7 represents a glyco-immune checkpoint for non-exhausted effector memory CD8+ T cells with high functional and metabolic capacities
por: Haas, Quentin, et al.
Publicado: (2022)

Interactions of Human Myeloid Cells with Natural Killer Cell Subsets In Vitro and In Vivo
por: Chijioke, Obinna, et al.
Publicado: (2011)

Dendritic Cell Derived Cytokines in Human Natural Killer Cell Differentiation and Activation
por: Chijioke, Obinna, et al.
Publicado: (2013)

Natural killer cells in herpesvirus infections
por: Münz, Christian, et al.
Publicado: (2017)

NLRC5 shields T lymphocytes from NK-cell-mediated elimination under inflammatory conditions
por: Ludigs, Kristina, et al.
Publicado: (2016)

(NZW × BXSB) F1 male mice: An unusual, severe and fatal mouse model of lupus erythematosus
por: Almizraq, Ruqayyah J., et al.
Publicado: (2022)

Antitumor effects of the GM3(Neu5Gc) ganglioside-specific humanized antibody 14F7hT against Cmah-transfected cancer cells
por: Dorvignit, Denise, et al.
Publicado: (2019)

Modulation of Neutrophil Function by Recombinant Human IgG1 Fc Hexamer in the Endogenous K/BxN Mouse Model of Rheumatoid Arthritis
por: Almizraq, Ruqayyah J., et al.
Publicado: (2023)

Glycocalyx Engineering Reveals a Siglec-Based Mechanism for NK Cell Immunoevasion
por: Hudak, Jason E., et al.
Publicado: (2013)

Reduced frequency of cytotoxic CD56(dim) CD16(+) NK cells leads to impaired antibody-dependent degranulation in EBV-positive classical Hodgkin lymphoma
por: Pánisová, Elena, et al.
Publicado: (2021)

Identification of Siglec-9 as the receptor for MUC16 on human NK cells, B cells, and monocytes
por: Belisle, Jennifer A, et al.
Publicado: (2010)

Small Molecule Drugs That Inhibit Phagocytosis
por: Loriamini, Melika, et al.
Publicado: (2023)

Siglec-7 expression is reduced on a natural killer (NK) cell subset of obese humans
por: Rosenstock, Philip, et al.
Publicado: (2017)

Evaluation of Radiolabeled Girentuximab In Vitro and In Vivo
por: Basaco, Tais, et al.
Publicado: (2018)

A Cartography of Siglecs and Sialyltransferases in Gynecologic Malignancies: Is There a Road Towards a Sweet Future?
por: Haas, Quentin, et al.
Publicado: (2018)

Xenogeneic Neu5Gc and self-glycan Neu5Ac epitopes are potential immune targets in MS
por: Boligan, Kayluz F., et al.
Publicado: (2020)

Attack of the clones: An NK cell origins story
por: Caporale, Joseph R., et al.
Publicado: (2023)

Unique repertoire of anti-carbohydrate antibodies in individual human serum
por: Luetscher, Ralph N. D., et al.
Publicado: (2020)

Siglec Ligands
por: Gonzalez-Gil, Anabel, et al.
Publicado: (2021)

Sialic acids in pancreatic cancer cells drive tumour-associated macrophage differentiation via the Siglec receptors Siglec-7 and Siglec-9
por: Rodriguez, Ernesto, et al.
Publicado: (2021)

Molecular cloning of porcine Siglec-3, Siglec-5 and Siglec-10, and identification of Siglec-10 as an alternative receptor for porcine reproductive and respiratory syndrome virus (PRRSV)
por: Xie, Jiexiong, et al.
Publicado: (2017)

THP-1 cells transduced with CD16A utilize Fcγ receptor I and III in the phagocytosis of IgG-sensitized human erythrocytes and platelets
por: Gil Gonzalez, Lazaro, et al.
Publicado: (2022)

MicroRNAs of Epstein-Barr Virus Attenuate T-Cell-Mediated Immune Control In Vivo
por: Murer, Anita, et al.
Publicado: (2019)

Modular adjuvant-free pan-HLA-DR-immunotargeting subunit vaccine against SARS-CoV-2 elicits broad sarbecovirus-neutralizing antibody responses
por: Kassardjian, Audrey, et al.
Publicado: (2023)

Coevolution of Siglec-11 and Siglec-16 via gene conversion in primates
por: Hayakawa, Toshiyuki, et al.
Publicado: (2017)

Erratum for Murer et al., “MicroRNAs of Epstein-Barr Virus Attenuate T-Cell-Mediated Immune Control In Vivo”
por: Murer, Anita, et al.
Publicado: (2019)

The Roles of Siglec7 and Siglec9 on Natural Killer Cells in Virus Infection and Tumour Progression
por: Zheng, Yayun, et al.
Publicado: (2020)

STAT1 signaling shields T cells from NK cell-mediated cytotoxicity
por: Kang, Yu Hui, et al.
Publicado: (2019)

A Developed NK-92MI Cell Line with Siglec-7(neg) Phenotype Exhibits High and Sustainable Cytotoxicity against Leukemia Cells
por: Huang, Chin-Han, et al.
Publicado: (2018)

Medulloblastoma rendered susceptible to NK-cell attack by TGFβ neutralization
por: Powell, Allison B., et al.
Publicado: (2019)

The Role of Siglec-G on Immune Cells in Sepsis
por: Royster, William, et al.
Publicado: (2021)

Siglecs at the Host–Pathogen Interface
por: Chang, Yung-Chi, et al.
Publicado: (2020)

Siglecs as Therapeutic Targets in Cancer
por: Lim, Jackwee, et al.
Publicado: (2021)

Siglec Signaling in the Tumor Microenvironment
por: van Houtum, Eline J. H., et al.
Publicado: (2021)

Siglec-7 glyco-immune binding mAbs or NK cell engager biologics induce potent antitumor immunity against ovarian cancers
por: Bordoloi, Devivasha, et al.
Publicado: (2023)

Virus-specific CD4(+) T cells: ready for direct attack
por: Heller, Kevin N., et al.
Publicado: (2006)

Human Dendritic Cells Activate Resting Natural Killer (NK) Cells and Are Recognized via the NKp30 Receptor by Activated NK Cells
por: Ferlazzo, Guido, et al.
Publicado: (2002)

Sialic Acids on Tumor Cells Modulate IgA Therapy by Neutrophils via Inhibitory Receptors Siglec-7 and Siglec-9
por: Chan, Chilam, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_qq3isi4k6c16to8aljh6qlo2a6